Peptides are short chains of amino acids — the body's own signaling molecules. In therapeutic use, they instruct cells to repair tissue, regulate hormones, reduce inflammation, and tune metabolic rhythm.
Each profile opens with status, mechanism, and a one-line summary so you can decide in seconds whether the rest is worth your reading time. The full record — dosing, half-life, and citation chain — unfolds below.
Browse all 47 profiles
* Ranked by combined study volume, search demand, and clinician-flagged questions over the last 90 days.
Semaglutide
“The peptide that reshaped obesity medicine.”
Mechanism
GLP-1 receptor agonist — mimics the incretin hormone GLP-1 to slow gastric emptying, reduce appetite, and improve glycemic control via pancreatic beta-cell stimulation.
Class
Metabolic Health
Studies
5
Tirzepatide
“Next-generation dual-receptor agonist rewriting weight loss benchmarks.”
Mechanism
Dual GIP/GLP-1 receptor agonist — simultaneously activates both incretin hormone receptors to produce additive metabolic effects exceeding GLP-1 agonism alone.
Class
Metabolic Health
Studies
4
Body Protection Compound 157
“The body's own repair signal, amplified.”
Mechanism
Upregulates growth hormone receptor expression, promotes angiogenesis, and modulates nitric oxide synthesis in damaged tissue.
Class
Recovery
Studies
4
Thymosin Beta-4 Fragment
“Accelerated healing at the cellular level.”
Mechanism
Actin-sequestering peptide that promotes cell migration, angiogenesis, and anti-inflammatory signaling through Tβ4 receptor pathways.
Class
Recovery
Studies
4
Peptides don't promise more — they promise more precision. The body already speaks this language; we're just learning to listen for the verbs that matter.
Eighteen therapeutic categories, each scored by evidence depth and peptide count. Open one to see the compounds with the strongest signal for that goal — and the questions still being asked.
Search by name, mechanism, condition, or evidence grade. Filter by FDA status. Compare side-by-side.
↳ Currently trending
Currently trending
Body Protection Compound 157
GLP-1 Receptor Agonist
Dual GIP/GLP-1 Receptor Agonist
Bremelanotide (Vyleesi)
ACTH(4-7) Analog
Copper Tripeptide-1
Everything you need before your first protocol — how peptides work, what the research shows, how to evaluate a provider, and what questions to ask.
An evidence-graded review of GLP-1 agonists, AOD-9604, and other metabolic peptides — separating marketing claims from peer-reviewed findings.
The most comprehensive review of BPC-157 available — covering 48+ studies, proposed mechanisms, dosing considerations, and open research questions.
One email each Friday. New peptide approvals, landmark studies, protocol updates, and clinician-flagged questions — distilled into a single scannable digest.
Weekly briefings on new clinical studies, peptide approvals, protocol updates, and emerging research — curated for practitioners.
